Mounjaro (tirzepatide) : The SURMOUNT trials demonstrated even greater efficacy, with average weight loss of 22.5% at the highest dose after 72 weeks
Loreft B, Ganowiak W, Wissing U, Granrus AK, Unosson M
Although the aforementioned human studies provide important insights into the role of PYY in human metabolism, there are notable inconsistencies within the existing evidence, and these studies themselves have several key limitations that warrant cautious interpretation
Others struggle with the ongoing cost, insurance coverage, medication shortages, or the long-term commitment required to stay on treatment
Green synthesis of silver nanoparticles, graphene, and silver-graphene nanocomposite using Melissa officinalis ethanolic extract: Anticancer effect on MCF-7 cell line
The absence of verified dosing, product identity, and medical history means that individual case causality cannot be established with the certainty afforded by a controlled clinical trial